tiprankstipranks
Advertisement
Advertisement
Sionna Therapeutics files automatic mixed securities shelf
PremiumThe FlySionna Therapeutics files automatic mixed securities shelf
2M ago
Sionna Therapeutics files automatic mixed securities shelf
Premium
The Fly
Sionna Therapeutics files automatic mixed securities shelf
2M ago
Sionna Therapeutics reports Q4 EPS (46c), consensus (55c)
Premium
The Fly
Sionna Therapeutics reports Q4 EPS (46c), consensus (55c)
2M ago
Coty downgraded, Spruce Biosciences initiated: Wall Street’s top analyst calls
PremiumThe FlyCoty downgraded, Spruce Biosciences initiated: Wall Street’s top analyst calls
4M ago
Sionna Therapeutics initiated with an Outperform at LifeSci Capital
Premium
The Fly
Sionna Therapeutics initiated with an Outperform at LifeSci Capital
4M ago
Sionna Therapeutics: NBD1-Targeted CFTR Stabilization Strategy Positions Pipeline for Best-in-Class Efficacy and Blockbuster Upside in Cystic Fibrosis
Premium
Ratings
Sionna Therapeutics: NBD1-Targeted CFTR Stabilization Strategy Positions Pipeline for Best-in-Class Efficacy and Blockbuster Upside in Cystic Fibrosis
4M ago
Sionna Therapeutics: Promising Developments and Strategic Advancements Boost Price Target
PremiumRatingsSionna Therapeutics: Promising Developments and Strategic Advancements Boost Price Target
5M ago
Sionna Therapeutics Advances CF Pipeline Amid Strong Financials
Premium
Company Announcements
Sionna Therapeutics Advances CF Pipeline Amid Strong Financials
6M ago
Sionna Therapeutics reports Q3 EPS (46c), consensus (47c)
Premium
The Fly
Sionna Therapeutics reports Q3 EPS (46c), consensus (47c)
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100